Evidence map›Paper›PMID 40330793›Full record

ArticleGlobal health, epidemiology and genomics2025

Identification of Significant Mutations in Spike Protein of SARS-CoV-2 Variants of Concern and the Discovery of Potent Inhibitors.

Mohsen Almakrami, Mohammed Bazuqamah, Mohammed A Alshehri, Abdulaziz M S Alqahtani, Sultan F Kadasah, Naif Harthi, Rami Ali Alyami, Abdulmajeed Alqurashi, Abdulhadi A Al Ruwaithi

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Global health, epidemiology and genomics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Mohsen AlmakramiDepartment of Pathology and Laboratory Medicine, King Khaled Hospital, Najran 66262, Saudi Arabia.ORCID https://orcid.org/0009-0002-2595-5009
Mohammed BazuqamahDepartment of Pathology and Laboratory Medicine, King Khaled Hospital, Najran 66262, Saudi Arabia.ORCID https://orcid.org/0000-0003-0865-8563
Mohammed A AlshehriDepartment of Medical Laboratory, College of Applied Medical Sciences, Prince Sattam Bin Abdulaziz University, Al-Kharj 11942, Saudi Arabia.ORCID https://orcid.org/0009-0006-2139-5904
Abdulaziz M S AlqahtaniDepartment of Biology, Faculty of Science, University of Bisha, P.O. Box 551, Bisha 61922, Saudi Arabia.ORCID https://orcid.org/0009-0004-5753-7199
Sultan F KadasahDepartment of Biology, Faculty of Science, University of Bisha, P.O. Box 551, Bisha 61922, Saudi Arabia.ORCID https://orcid.org/0000-0001-8077-3668
Naif HarthiEmergency Medical Services, Faculty of Applied Medical Sciences, Jazan University, Jazan, Saudi Arabia.ORCID https://orcid.org/0000-0002-7065-6502
Rami Ali AlyamiRespiratory Therapy Department, Faculty of Applied Medical Sciences, Jazan University, Jazan, Saudi Arabia.
Abdulmajeed AlqurashiDepartment of Biology, College of Science, Taibah University, Madinah 42353, Saudi Arabia.ORCID https://orcid.org/0009-0002-0434-8154
Abdulhadi A Al RuwaithiDepartment of Clinical Technology, Umm Al-Qura University, Makkah, Saudi Arabia.ORCID https://orcid.org/0000-0001-6768-6463

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antiviral AgentsCOVID-19 Drug TreatmentMutationSARS-CoV-2Spike Glycoprotein, CoronavirusCOVID-19Drug DiscoveryHumansMolecular Docking SimulationAntiviral AgentsSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2mutationsomicronSARS-CoV-2spike proteinvariant of concern (VoC)

Identifiers

PMID40330793
PMCPMC12052452

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.